UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
LM FUNDING AMERICA, INC. |
|
(Name of Issuer) |
|
Common Shares with par value of $0.001 per share |
|
(Title of Class of Securities) |
|
502074305 |
|
(CUSIP Number) |
|
Mark Pajak Craven House Capital North America LLC 107 West Federal St, PO Box 480 Middleburg VA 20118-0480 +1 540 687 3166 |
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
|
18th August 2020 |
|
(Date of Event which Requires Filing of this Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for sched13dany subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
CUSIP No. 502074305 |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
Craven House Capital North America LLC EIN# 36-4886491 |
||||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|||
|
(a) [ ] (b) [ ] |
||||
|
3 |
SEC USE ONLY |
|||
|
4 |
SOURCE OF FUNDS (See Instructions) |
|||
|
WC |
||||
|
5 |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) |
|||
|
[ ] |
||||
|
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION |
|||
|
Florida |
||||
|
NUMBER OF |
7 |
SOLE VOTING POWER |
||
|
150,000 shares |
||||
|
8 |
SHARED VOTING POWER |
|||
|
0 |
||||
|
9 |
SOLE DISPOSITIVE POWER |
|||
|
150,000 shares |
||||
|
10 |
SHARED DISPOSITIVE POWER |
|||
|
0 |
||||
|
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|||
|
150,000 shares |
||||
|
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) |
|||
|
[ ] |
||||
|
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
|||
|
1.1% |
||||
|
14 |
TYPE OF REPORTING PERSON (See Instructions) |
|||
|
CO |
||||
*See item 6 below
Page 2
Item 1. Security and Issuer
Common shares with par value of $0.001 per share.
LM Funding America, Inc. 302 Knights Run Avenue, Suite 1000, Tampa, Florida 33602
Item 2. Identity and Background
(a) Craven House Capital North America LLC
(b) 2033 Main St, Suite 600, Sarasota, Florida, 34237
(c) Holding company.
(d) No
(e) No
(f) N/A
Item 3. Source and Amount of Funds or Other Considerations
Source of funds is from internal working capital of the reporting person. Total consideration of $135,000
Item 4. Purpose of Transaction
A general investment held by the reporting person.
Item 5. Interest in Securities of the Issuer
(a) 150,000 common shares with par value of $0.001. Aggregate 150,000 shares representing 1.1% of the issued common shares of the Issuer.
(b) 150,000
(c) Purchase of 150,000 common shares.
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
N/A
Item 7. Material to Be Filed as Exhibits
N/A
Page 3
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
25th August 2020 |
|
|
Dated |
|
|
/s/ Mark J. Pajak |
|
|
Signature |
|
|
Mark Pajak - Manager |
|
|
Name/Title |
|
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).